Perforin pathway is essential for protection of mice against lethal ocular HSV-1 challenge but not corneal scarring

Virus Research

Volumn 65, Issue 2, 1999, Pages 97-101

  Ghiasi, Homayon ^a,b   Cai, Steve ^a   Perng, Guey Cheun ^a   Nesburn, Anthony B ^a,b   Wechsler, Steven L ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Eye disease; HSV 1; Ocular; Perforin; Protection

Indexed keywords

PERFORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; INFECTION SENSITIVITY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SCAR FORMATION; STRAIN DIFFERENCE; SURVIVAL RATE; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VIRUS KERATITIS;

ANIMALS; CORNEA; FEMALE; HERPESVIRUS 1, HUMAN; KERATITIS, HERPETIC; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PORE FORMING CYTOTOXIC PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, ATTENUATED; VIRAL VACCINES;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 1;

EID: 0032726606     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(99)00107-0     Document Type: Article

References (32)

1. Bonneau R.H., Jennings S.R. Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J. Virol. 63:1989;1480-1484.
2. Bonneau R.H., Jennings S.R. Herpes simplex virus-specific cytolytic T lymphocytes restricted to a normally low responder H-2 allele are protective in vivo. Virology. 174:1990;599-604.
3. Garcia-Sanz J.A., Plaetinck G., Velotti F., Masson D., Tschopp J., MacDonald H.R., Nabholz M. Perforin is present only in normal activated Lyt2+ T lymphocytes and not in L3T4+ cells, but the serine protease granzyme A is made by both subsets. EMBO J. 6:1987;933-938.
4. Ghiasi H., Bahri S., Nesburn A.B., Wechsler S.L. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest. Ophthalmol. Vis. Sci. 36:1995;1352-1360.
5. Ghiasi H., Cai S., Nesburn A.B., Wechsler S.L. MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1. Curr. Eye Res. 16:1997;1152-1158.
6. Ghiasi H., Kaiwar R., Nesburn A.B., Slanina S., Wechsler S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gl): comparative protection against lethal challenge in mice. J. Virol. 68:1994;2118-2126.
7. Ghiasi H., Nesburn A.B., Kaiwar R., Wechsler S.L. Immunoselection of recombinant baculovinuses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D. Arch. Virol. 121:1991;163-178.
8. Ghiasi H., Roopenian D.C., Slanina S., Cai S., Nesburn A.B., Wechsler S.L. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge. Immunology. 91:1997;430-435.
9. Ghiasi H., Wechsler S.L., Cai S., Nesburn A.B., Hofman F.M. The role of neutralizing antibody and T-helper subtypes in protection and pathogenesis of vaccinated mice following ocular HSV-1. Immunology. 95:1998;352-359.
10. Hanke T., Graham F.L., Rosenthal K.L., Johnson D.C. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65(11):1991;77-1186.
11. Kagi D., Ledermann B., Burki K., Hengartner H., Zinkemagel R.M. CD8+ T cell-mediated protection against an intracellular bacterium by perforin dependent cytotoxicity. Eur. J. Immunol. 24:1994a;3068-3072.
12. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:1994b;31-37.
13. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkemagel R.M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369(6475):1994c;31-37.
14. Kojima H., Shinohara N., Hanaoka S., Someya-Shirota Y., Takagaki Y., Ohno H., Saito T., Katayama T., Yagita H., Okumura K. et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity. 1:1994;357-364.
15. Lausch R.N., Monteiro C., Kleinschrodt W.R., Oakes J.E. Superiority of antibody versus delayed hypersensitivity in clearance of HSV-1 from eye. Invest. Ophthalmol. Vis. Sci. 28:1987;565-570.
16. Lausch R.N., Staats H., Metcalf J.F., Oakes J.E. Effective antibody therapy in herpes simplex virus ocular infection. Characterization of recipient immune response. Intervirology. 31:1990;159-165.
17. Lin M.T., Stohlman S.A., Hinton D.R. Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J. Virol. 71:1997;383-391.
18. Martin S., Zhu X.X., Silverstein S.J., Courtney R.J., Yao F., Jenkins F.J., Rouse B.T. Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0. J. Gen. Virol. 71:1990;2391-2399.
19. Matloubian M., Suresh M., Glass A., Galvan M., Chow K., Whitmire J.K., Walsh C.M., Clark W.R., Ahmed R. A role for perforin in downregulating T-cell responses during chronic viral infection. J. Virol. 73:1999;2527-2536.
20. Mullbacher A., Hla R.T., Museteanu C., Simon M.M. Perforin is essential for control of ectromelia virus but not related poxviruses in mice. J. Virol. 73(2):1999;1665-1667.
21. Nash A.A., Jayasuriya A., Phelan J., Cobbold S.P., Waldmann H., Prospero T. Different roles for L3T4+ and Lyt2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Virol. 68:1987;825-833.
22. Otten G.R., Germain R.N. Split anergy in a CD8+ T cell: receptor dependent cytolysis in the absence of interleukin-2 production. Science. 251:1991;1228-1231.
23. Pfizenmaier K., Jung H., Starzinski-Powitz A., Rollinghoff M., Wagner H. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigenspecific cytotoxic T lymphocytes. J. Immunol. 119:1977a;939-944.
24. Pfizenmaier K., Starzinski-Powitz A., Rollinghoff M., Falks D., Wagner H. T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells. Nature. 265:1977b;630-632.
25. Pircher H., Moskophidis D., Rohrer U., Burki K., Hengartner H., Zinkemagel R.M. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 346:1990;629-633.
26. Podack E.R., Lowrey D.M., Lichtenheld M., Olsen K.J., Aebischer T., Binder D., Rupp F., Hengartner H. Structure, function and expression of murine and human perforin 1 (P1). Immunol. Rev. 103:1988;203-211.
27. Rossi C.P., McAllister A., Tanguy M., Kagi D., Brahic M. Theiler's virus infection of perforin-deficient mice. J. Virol. 72:1998;4515-4519.
28. Rouvier E., Luciani M.F., Golstein P. Fas involvement in Ca(2+) independent T cell-mediated cytotoxicity. J. Exp. Med. 177:1993;195-200.
29. Sambhara S., Switzer I., Kurichh A., Miranda R., Urbanczyk L., James O., Underdown B., Klein M., Burt D. Enhanced antibody and cytokine responses to influenza viral antigens in perforin-deficient mice. Cell Immunol. 187:1998;13-18.
30. Sethi K.K., Omata Y., Schneweis K.E. Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes. J. Gen. Virol. 64:1983;443-447.
31. Usherwood E.J., Brooks J.W., Sarawar S.R., Cardin R.D., Young W.D., Allen D.J., Doherty P.C., Nash A.A. Immunological control of murine gammaherpesvirus infection is independent of perforin. J. Gen. Virol. 78:1997;2025-2030.
32. Walsh C.M., Matloubian M., Liu C.C., Ueda R., Kurahara C.G., Christensen J.L., Huang M.T., Young J.D., Ahmed R., Clark W.R. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA. 91:1994;10854-10858.